Kevin Sayer | Chairman, President and CEO |
Jereme Sylvain | Chief Financial Officer |
Jake Leach | Chief Technology Officer |
Sean Christensen | Head of Investor Relations |
Quen Blackford | Chief Operating Officer |
Jeff Johnson | Baird |
Robbie Marcus | JP Morgan |
Danielle Antalffy | SVB Leerink |
Matthew Blackman | Stifel |
Margaret Kaczor | William Blair |
Matthew O'Brien | Piper Sandler |
Travis Hayes | Barclays |
Matt Taylor | UBS |
Joanne Wuensch | Citi |
Cecilia Furlong | Morgan Stanley |
Jayson Bedford | Raymond James |
Nathan Travis | Wells Fargo |
Steven Lichtman | Oppenheimer |
Ravi Misra | Berenberg |
Maury Kibo | BTIG |
Neal | Cowen |
Anthony Petrone | Jefferies |
Kyle Rose | Canaccord |
Chris Pasquale | Guggenheim |
Welcome to the DexCom | Third Quarter 2021 earnings release conference call. My name is Darrell and I will be your operator for today's call at this time - all participants are in a listen-only mode. Later we will conduct a question-and-answer session. During the question-and-answer session [Operator Instruction]. Please note that this conference is being recorded. I will now turn the call over to Sean Christiansen (ph) - Sean - you may begin. |
Thank you, Operator. And welcome to DexCom's Third Quarter 2021 Earnings Call.
Our agenda begins with Kevin Sayer, DexCom's Chairman, President and CEO, who will provide a summary of our progress on our third quarter highlights and strategic initiatives, followed by a financial review and outlook from Jeremy Sylvain, our Chief Financial Officer.
Following our prepared remarks, we will open the call up for your questions.
Our Chief Technology Officer, Jake Leach, will also be present with us for the Q&A period.